Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 12487216)

Published in Ann Allergy Asthma Immunol on December 01, 2002

Authors

David B Allen

Articles by these authors

Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10

Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program: a randomized, controlled study. Arch Pediatr Adolesc Med (2005) 2.96

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr (2004) 1.91

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab (2013) 1.74

Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J Pediatr (2005) 1.54

School-based fitness changes are lost during the summer vacation. Arch Pediatr Adolesc Med (2007) 1.51

Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol (2006) 1.39

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab (2002) 1.22

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab (2010) 1.11

Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A (2007) 1.10

Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. Ann Allergy Asthma Immunol (2007) 1.00

Standardized childhood fitness percentiles derived from school-based testing. J Pediatr (2012) 0.98

Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol (2009) 0.96

Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol (2011) 0.90

Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr (2003) 0.90

School-based exercise improves fitness, body composition, insulin sensitivity, and markers of inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.88

Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol (2005) 0.88

Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol (2015) 0.88

Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr (2010) 0.87

Submaximal treadmill test predicts VO2max in overweight children. J Pediatr (2009) 0.86

Reliable prediction of insulin resistance by a school-based fitness test in middle-school children. Int J Pediatr Endocrinol (2009) 0.84

Off the growth curve: the challenge of childhood obesity. WMJ (2005) 0.84

TODAY--a stark glimpse of tomorrow. N Engl J Med (2012) 0.84

Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity (Silver Spring) (2013) 0.82

Childhood obesity and medical neglect. Pediatrics (2009) 0.81

Fitness level and body composition are associated with inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.81

Inhaled corticosteroids, growth, and compliance. N Engl J Med (2002) 0.80

Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead. J Clin Endocrinol Metab (2010) 0.79

Gender and race influence metabolic benefits of fitness in children: a cross-sectional study. Int J Pediatr Endocrinol (2012) 0.78

Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers. Clin Pediatr (Phila) (2007) 0.78

Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr (2013) 0.78

Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis. Int J Pediatr Endocrinol (2010) 0.78

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr (2016) 0.77

Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome. Horm Res Paediatr (2016) 0.77

In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI. Horm Res Paediatr (2015) 0.77

Poor glycemic control predicts occurrence and progression of microalbuminuria in children with type I diabetes. J Pediatr (2008) 0.75

Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone Secretion Testing. Int J Pediatr Endocrinol (2010) 0.75

Additional sensitivity data for newborn screening for congenital adrenal hyperplasia in Wisconsin. J Pediatr (2006) 0.75

Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty. Sports Health (2011) 0.75

The influence of fitness on insulin resistance in obese children. Rev Endocr Metab Disord (2009) 0.75

Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2007) 0.75

Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2008) 0.75

Disparities in Fitness and Physical Activity Among Children. WMJ (2017) 0.75

Treating short stature with growth hormone. Virtual Mentor (2005) 0.75

Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence. Curr Opin Pediatr (2017) 0.75

Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology
. Horm Res Paediatr (2017) 0.75

Topical fluticasone propionate lotion does not cause HPA axis suppression. J Pediatr (2006) 0.75